Skip to content

OPTI-FREE PUREMOIST OPTI-FREE PUREMOIST 10ozRecalls & reported problems

Alcon Laboratories, Inc. · Opti-Free Pure Moist Multi-Purpose Disinfecting Solution 10 oz. · Class 2

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
2
Deaths reported
0
Injuries reported
2
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00300650361040), received between Aug 25, 2023 and Nov 3, 2023 — classified as 2 injuries.

The most frequently reported specific device problem is “Device Emits Odor” (2 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 1 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Device Emits Odor2

Patient problems

  • Eye Pain2
  • Foreign Body Sensation in Eye2
  • Fungal Infection2
  • Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available1
  • Blurred Vision1
  • Conjunctivitis1
  • Dry Eye(s)1
  • Excessive Tear Production1

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • InjuryNov 3, 2023Device Emits Odor; Device Emits Odor

    ON 30/NOV/2023, ADDITIONAL INFORMATION HAS BEEN RECEIVED STATES THAT CONSUMER WAS TREATED WITH MOXIFLOXACIN 0.5%, 3ML OPHTHALMIC SOLUTION AND PREDNISONE 1% 15ML OPHTHALMIC SUSPENSION EYE DROPS FOR THE EYE INFECTION. ADDITIONALLY, THE CONSUMER WAS TREATED WITH PREDNISONE 20MG TABLETS, KETOCONAZOLE 2% SHAMPOO 120ML, CIPROFLOXACIN 500MG TABLET, AND TRIAMCINOLONE 0.1% OINTMENT 80GM FOR SINUS AND SKIN RASHES. THE CURRENT CONDITION OF CONSUMER'S EYE IS SYMPTOMS RESOLVED, WITH THE AVAILABLE INFORMATION THE CASE STILL RETAIN AS SERIOUS AND REPORTABLE.

    Patient problems: Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available; Conjunctivitis; Eye Pain; Foreign Body Sensation in Eye; Fungal Infection; Headache; Hemorrhage/Blood Loss/Bleeding; Rash

    MAUDE report 18065296 ↗
  • InjuryAug 25, 2023Device Emits Odor; Device Emits Odor

    INITIALLY RECEIVED FROM CONSUMER STATING THAT THE CONSUMER EXPERIENCED PUS, DRY EYE, BURNING, BLURRY VISION, SOLUTION SMELLED DIFFERENT, IRRITATION, TEARING, REDEYES AND EYE PAIN. FUNGAL INFECTION WAS THE DIAGNOSIS AND EYE DROPS WERE TAKEN. CURRENT PATIENT'S CONDITION IS SYMPTOMS CONTINUING. ADDITIONAL INFO HAS BEEN REQUESTED.

    Patient problems: Blurred Vision; Dry Eye(s); Excessive Tear Production; Eye Burn; Eye Pain; Foreign Body Sensation in Eye; Fungal Infection; Purulent Discharge; Red Eye(s)

    MAUDE report 17624608 ↗

Other Accessories, soft lens products devices

All Accessories, soft lens products devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page